![Samit Hirawat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Samit Hirawat is currently an Independent Director at Pacira Biosciences, Inc. starting in 2026.
Formerly, Dr. Hirawat was Chief Medical Officer-Global Drug Development at Bristol Myers Squibb Co. from 2019 to 2025 and Head- Global Oncology Development at Novartis AG from 2017 to 2019.
Education includes an undergraduate degree from SMS Medical College & Hospital.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/03/2026 | 31.925 ( 0 % ) | 2 M $ | 30/06/2026 | |
PACIRA BIOSCIENCES, INC. 0,02 % | 10/06/2026 | 6.405 ( 0,02 % ) | 162 495 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director/Miembro de la Junta | 27/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director Técnico/Científico/I+D | 01/08/2025 |
| NOVARTIS AG | Corporate Officer/Principal | 01/06/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
 SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
